Blue Edge Capital LLC Decreases Stake in Merck KGaA $MKGAF

Key Points

• Blue Edge Capital LLC cut its Merck KGaA stake by 39.1% in the second quarter, selling 7,392 shares and retaining 11,499 shares valued at approximately $1.48 million.
• Several other institutional investors initiated positions in Merck KGaA during the quarter, though institutional and hedge-fund ownership remains limited at 0.10%.
• Merck KGaA shares recently traded down 3.9% to $158.15, with a market capitalization of about $20.44 billion and a 52-week trading range of $116.68 to $175.56.

Blue Edge Capital LLC lowered its holdings in Merck KGaA (OTCMKTS:MKGAF - Free Report) by 39.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,499 shares of the company's stock after selling 7,392 shares during the period. Blue Edge Capital LLC's holdings in Merck KGaA were worth $1,478,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Frazier Financial Advisors LLC purchased a new position in Merck KGaA in the second quarter valued at about $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA in the second quarter valued at about $27,000. Delos Wealth Advisors LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at about $33,000. Solstein Capital LLC acquired a new position in Merck KGaA during the 2nd quarter worth approximately $33,000. Finally, Burk Holdings LLC purchased a new position in Merck KGaA in the 2nd quarter worth approximately $39,000. Institutional investors and hedge funds own 0.10% of the company's stock.

Merck KGaA Trading Down 3.9%

MKGAF opened at $158.15 on Friday. The firm's 50 day moving average is $163.21 and its 200-day moving average is $148.95. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $20.44 billion, a P/E ratio of 24.14 and a beta of 0.96.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company's operations are organized mainly into three businesses.

Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source